Agilent Technologies Inc. has opened its first training facility in Asia at Yishun, Singapore. Known as Agilent University, the 10,000-squareâfoot training facility includes three stateâofâtheâart laboratories and will offer more than 200 technology courses on techniques such as mass spectroscopy (MS), gas chromatography (GC), and liquid chromatography (LC). The training will primarily be offered to Agilent customers and field support engineers as well as the general public in the Asia Pacific and Middle East regions. Chow Woai-Sheng, Agilent Singapore country general manager and Agilent vice president of global supply chain and logistics, commented: “The comprehensive training we deliver will help our customers - whether lab technicians or cuttingâedge researchers - meet today’s most complex challenges and enhance lab productivity.” Guest of honour Ms. Thien Kwee Eng, assistant managing director, Singapore Economic Development Board, said, “Singapore’s life science tools and diagnostics sector is wellâpositioned for growth, with the sector growing by more than two times in terms of output and employment over the last five years. We welcome Agilent’s latest investment, and look forward to deepening this partnership even further.” Mr. Mike McMullen, the CEO of Agilent Technologies, confirmed in his keynote address that the life sciences market is growing rapidly with Singapore prepped to become a major scientific hub for the life sciences. The facility also marks Agilent’s continued investment in Singapore. In 2010, Agilent opened a life sciences instruments manufacturing facility here to meet global demands for LC–MS instruments. For more information please visit www.agilent.com
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.